SCHEMBL3601422

SCHEMBL3601422

CC(C)(C)OC(=O)N1CCc2cc(C(=O)Nc3cnn(COc4cccc(C(F)(F)F)c4)c3)ccc2C1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 1/20 0.43
BRAF P15056 1/20 0.43
ESR2 Q92731 1/20 0.42
JAK2 O60674 1/20 0.42
JAK3 P52333 1/20 0.42
PTK2 Q05397 1/20 0.42
ALDH1A1 P00352 1/20 0.41
NAMPT P43490 4/20 0.41
SCD O00767 1/20 0.41
SCD5 Q86SK9 1/20 0.41
MAPT P10636 3/20 0.40
RAB9A P51151 1/20 0.40
POLB P06746 1/20 0.40
RXFP1 Q9HBX9 1/20 0.39
GAA P10253 1/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KDR P35968 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3610635 0.90 NAMPT (0.48) ESR2ALDH1A1NAMPTSCDSCD5
SCHEMBL3603799 0.88 SCD5 (0.51) RAF1BRAFESR2JAK2JAK3
SCHEMBL3611560 0.86 MAPT (0.47) ESR2ALDH1A1NAMPTSCDSCD5
SCHEMBL3600477 0.84 NAMPT (0.51) ESR2JAK2JAK3PTK2NAMPT
SCHEMBL3602956 0.82 ALDH1A1 (0.43) ALDH1A1MAPTRAB9AGAAMAPK1
SCHEMBL3602755 0.81 SCD (0.51) ESR2ALDH1A1NAMPTSCDSCD5
Hydrochloric Acid SCHEMBL3601453 0.81 ALDH1A1 (0.42) ALDH1A1MAPTRAB9AGAAMAPK1
SCHEMBL3599343 0.81 ESR2 (0.46) ESR2ALDH1A1NAMPTSCDSCD5
SCHEMBL3601198 0.81 ESR2 (0.46) ESR2ALDH1A1NAMPTSCDSCD5
SCHEMBL3605783 0.80 NAMPT (0.56) NAMPTSCDSCD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8288538-B2 Pyridine derivatives and pyrimidine derivatives (3) EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-10-16 US disclosed
US-20100075944-A1 NOVEL PYRIDINE DERIVATIVES AND PYRIMIDINE DERIVATIVES (3) MATSUSHIMA TOMOHIRO 2010-03-25 US disclosed
US-20100041696-A1 Compounds SMITHKLINE BEECHAM CORPORATION 2010-02-18 US disclosed
US-6982348-B2 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-01-03 US disclosed
US-20040127574-A1 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041696-A1 Compounds CYP11B2, SCD, CYP3A5 RAF1 4581/4885BRAF 4677/4885ESR2 3025/4885
US-20040127574-A1 Aminoethanol derivatives CETP, LCAT, MTTP RAF1 2836/4885BRAF 4243/4885ESR2 395/4885
US-20100075944-A1 NOVEL PYRIDINE DERIVATIVES AND PYRIMIDINE DERIVATIVES (3) HGF, MET, HDGF RAF1 223/4885BRAF 60/4885ESR2 2803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.